These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15722694)

  • 1. Intensified screening and treatment of the metabolic syndrome for cardiovascular risk reduction.
    Wong ND
    Prev Cardiol; 2005; 8(1):47-52; quiz 53-4. PubMed ID: 15722694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome: cardiovascular risk assessment and management.
    Wong ND
    Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome: diagnosis and treatment.
    Zieve FJ
    Clin Cornerstone; 2004; 6 Suppl 3():S5-13. PubMed ID: 15707265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a Metabolic Syndrome Severity
    DeBoer MD; Filipp SL; Gurka MJ
    Diabetes Care; 2018 Nov; 41(11):2421-2430. PubMed ID: 30275282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome.
    Wang Y; Yu Q; Chen Y; Cao F
    Curr Pharm Des; 2013; 19(27):4799-805. PubMed ID: 23323622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High cardiometabolic risk in healthy Chilean adolescents: associations with anthropometric, biological and lifestyle factors.
    Burrows R; Correa-Burrows P; Reyes M; Blanco E; Albala C; Gahagan S
    Public Health Nutr; 2016 Feb; 19(3):486-93. PubMed ID: 25990645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome: therapeutic considerations.
    Grundy SM
    Handb Exp Pharmacol; 2005; (170):107-33. PubMed ID: 16596797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk.
    Said S; Mukherjee D; Whayne TF
    Curr Vasc Pharmacol; 2016; 14(5):415-425. PubMed ID: 27456105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.
    Carrington MJ; Zimmet P
    BMC Health Serv Res; 2017 Dec; 17(1):813. PubMed ID: 29212477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome.
    Garber AJ
    Med Clin North Am; 2004 Jul; 88(4):837-46, ix. PubMed ID: 15308381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging.
    Maggi S; Noale M; Gallina P; Bianchi D; Marzari C; Limongi F; Crepaldi G;
    J Gerontol A Biol Sci Med Sci; 2006 May; 61(5):505-10. PubMed ID: 16720749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
    García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
    J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: How does it work?
    Kränkel N; Bahls M; Van Craenenbroeck EM; Adams V; Serratosa L; Solberg EE; Hansen D; Dörr M; Kemps H
    Eur J Prev Cardiol; 2019 May; 26(7):701-708. PubMed ID: 30317879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome in children aged 5-9 years from southwest colombia: a cross-sectional study.
    Suarez-Ortegón MF; Aguilar-de Plata C
    World J Pediatr; 2016 Nov; 12(4):477-483. PubMed ID: 26830308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.
    Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a unifying hypothesis of metabolic syndrome.
    Bremer AA; Mietus-Snyder M; Lustig RH
    Pediatrics; 2012 Mar; 129(3):557-70. PubMed ID: 22351884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Syndrome: Systems Thinking in Heart Disease.
    Dommermuth R; Ewing K
    Prim Care; 2018 Mar; 45(1):109-129. PubMed ID: 29406938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Metabolic Syndrome in Children and Adolescents: Shifting the Focus to Cardiometabolic Risk Factor Clustering.
    Magge SN; Goodman E; Armstrong SC; ; ;
    Pediatrics; 2017 Aug; 140(2):. PubMed ID: 28739653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.